Ultra Legionella Inmunoanalysis System for Early Sensing

Projektinformationen

ULISENS

ID Finanzhilfevereinbarung: 726499

DOI 10.3030/726499

Abgeschlossenes Projekt

EK-Unterschriftsdatum 1 Juni 2016

Startdatum 1 Juni 2016

Enddatum 31 Mai 2018

Finanziert unter

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology

Gesamtkosten € 1 098 470,00

EU-Beitrag € 768 929,00

Koordiniert durch

BIOTICA BIOQUIMICA ANALITICA SL
Spain

Ziel

The general objective of ULISENS project is focused on the development and further commercialization of an automatic early warning system able to detect and quantify Legionella species in water. The system integrates an innovative fast detection biotechnology with an automatic module able to carry out “in situ” analysis in real-time to minimise time to results.
ULISENS reduces the legionellosis lethality from 12% to 2% because of TIMELY AND COST-EFFECTIVE INFORMATION to risk owners to take appropriate effective preventive measures as soon as possible. Therefore, it prevents shutdown times and costs, penalties of fines and discredit in face to their customers and the society. The benefit from each early detection using ULISENS (around 120,000€ per case) far exceeds the initial investment (20,000-60,000€).
ULISENS technical specifications:
- Faster response time, reducing time to result up to 99% compared to laboratory tests
- ICT Early warning system to prevent users from infection risks in real time.
- Lower cost, with reductions of up to 80% compared with standard laboratory tests
- Direct sampling from user’s network in real-time, no technical staff needed.
- Sustainable detection biotechnology without maintenance or biological waste generation.
- Great reduction of penalties and the discredit of the mark by human infections.
BIOTICA is a Spanish company specialized in the development of fast techniques for the microbiological detection and quantification based on the combination of recognition biomolecules, like antibodies, with advanced nanomaterials like paramagnetic particles. Up to now, they have focused on the research and development of the ULISENS system, by means of two R&D regional and national projects aimed at developing the prototype of the system and to validate in industrial facilities its performance and functionalities. The system is ready to go a step further in the development towards the future exploitation and commercialization.

Wissenschaftliches Gebiet

• medical and health sciences › clinical medicine › pneumology
• engineering and technology › electrical engineering, electronic engineering, information engineering › electronic engineering › control systems
• natural sciences › earth and related environmental sciences › hydrology
• social sciences › sociology › governance › crisis management
• engineering and technology › nanotechnology › nano-materials

Programm/Programme

• H2020-EU.2.1.4. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology Main Programme
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Thema/Themen

• SMEInst-03-2016-2017 - Dedicated support to biotechnology SMEs closing the gap from lab to market

Aufforderung zur Vorschlagseinreichung

H2020-SMEInst-2016-2017

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-SMEINST-2-2016-2017

Finanzierungsplan

SME-2 - SME instrument phase 2

Koordinator

BIOTICA BIOQUIMICA ANALITICA SL

• Netto-EU-Beitrag: € 768 929,00
• Adresse: PARQUE CIENTIFICO TECNOLOGICO Y EMPRESARIAL UNIVERSIDAD JAUME I CAMPUS RIU SEC AV SOS BAYNAT ED ESP ; 12071 CASTELLON ; Spanien
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Region
  Este › Comunitat Valenciana › Castellón/Castelló
• Region: Este › Comunitat Valenciana › Castellón/Castelló
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: € 1 098 470,00